Info

You are currently browsing the PFP Partnerships for Parkinson’s weblog archives for March, 2007.

March 2007
M T W T F S S
    Apr »
 1234
567891011
12131415161718
19202122232425
262728293031  

Archive for March 2007

Parkinson’s drug pulled from market

Seattle Post-Intelligencer ^ | March 29, 2007 | RANDOLPH E. SCHMID
Posted on 03/30/2007 7:22:48 PM PDT by neverdem
AP SCIENCE WRITER

WASHINGTON — A drug used by several thousand patients with Parkinson’s disease is being pulled from the market because of reports of heart valve damage.

The Food and Drug Administration said Thursday that pergolide, sold under the name Permax and also in generic versions, is being withdrawn at the agency’s request.

There are other drugs in the same class that can be substituted, Dr. Robert Temple of the FDA’s office of drug evaluation said at a briefing.

At least 14 patients have needed to have heart valves replaced, Temple said, adding he believes that is an underestimate.

He estimated that between 12,000 and 25,000 people currently used the drug, which is known as a dopamine agonist.

“Our conclusion is that pergolide has no demonstrated advantage over other therapies,” Temple said. “We believe almost all patients can be converted to another drug.”

Pergolide came on the market in 1988. Temple said label warnings were added in 2002 after some reports of heart valve problems were received.

In 2006, a boxed warning regarding the risk of serious heart valve damage was added to the labeling for pergolide.

Temple said withdrawal was requested after two recent studies, published in The New England Journal of Medicine, indicated high rates of valve leakage - up to 20 percent - in patients taking the drug.

He said patients should not stop using the drug abruptly, however, urging them to consult their doctor and either switch to another drug or to gradually reduce the amount of pergolide used.

Other dopamine agonists used for Parkinson’s disease are not associated with heart valve problems, FDA said.

Pergolide is marketed by Valeant under the trade name Permax and sold and manufactured as the generic drug pergolide by Par and Teva.

Temple said a few people may not be able to change to another drug and the agency is making arrangements to have pergolide available for them.

The new studies also found an increase chance of heart valve damage from another dopamine agonist, cabergoline, sold under the name Dostinex, the FDA said.

Dostinex is not approved in the U.S. for the treatment of Parkinson’s disease, but is used at lower doses for other disorders, Temple said. At the lower doses there appears to be little chance of heart problems, the agency said.

No Exaggeration: Parkinson’s Offers Lessons

Published: November 26, 2006
DAVID EGER does not exaggerate the tremor in his left hand nor the rigid leg that gives him a limp. So he was not amused when Rush Limbaugh accused Michael J. Fox of exaggerating his Parkinson’s symptoms in the actor’s commercial on behalf of political candidates who favor the stem-cell research that might yield a cure. 

”It was clear to me that Rush Limbaugh does not understand the illness,” Dr. Eger said, anger perceptible in his vivid blue eyes. ”It’s one thing to disagree with Michael on stem cells, but another to attack him and his illness, which I feel is unethical.”

Dr. Eger, 61, is a clinical psychologist here whose trim white beard and receding hairline give him a resemblance to the father of his profession, minus Freud’s cigar. Six years ago, his wife, Jane, noticed that his hand was lingering awkwardly on his dinner plate. He also couldn’t move his fingers deftly. He figured he had strained a nerve lifting weights. A neurologist told him otherwise.

”You have a problem,” the doctor said.

Parkinson’s, thought to affect a million Americans and, according to the Parkinson’s Support Group of Westchester, an estimated 300 people in the county, destroys brain cells that release the chemical messenger dopamine and progressively wears away at movement, mood, speech and memory. Symptoms can be restrained with drugs like Sinemet, but no cure has been found for the disease.

Most people told of life-altering illnesses fixate on their fate or search for relief. Dr. Eger did, too. He wondered how Jane, a clinical psychologist who shares his office suite, and his children would cope with watching him turn hobbled and frail.

”Instead of anticipating growing old together, it’s one well member of a couple taking care of the sick one,” he said.

But Dr. Eger did more than worry about himself. Like Mr. Fox, he decided to raise money for research. Indeed, a year after the disease was diagnosed, he and his family were vacationing in the Virgin Islands and ran into Mr. Fox outside a restaurant. It was like being told you have polio and running into Franklin Roosevelt.

”I was certainly struck by the coincidence, but I didn’t attribute it to divine intervention,” Dr. Eger said.

The actor was gracious and showed Dr. Eger his baby daughter, Esmé. The meeting, Dr. Eger said, ‘’sort of fired me up” and he focused his fund-raising on the Michael J. Fox Foundation for Parkinson’s Research. Working with musician friends like John Stine and Marsha Cheraskin Winokur, he arranged annual chamber music concerts at Rye Country Day School, the latest in October. According to Veronique Enos, the foundation’s major gifts officer, Dr. Eger has raised more than $160,000, one of the largest sums from a grass-roots group.

In doing the hard organizational work, he has taught friends a lesson: The grace and spirit with which we endure illness or dying is as much a measure of our character as the way we go about our most vigorous days.

”I can’t say I do it altruistically,” Dr. Eger said, slipping into the shrink’s role. ”It’s one of my ways of coping with the anxiety and fear that goes along with a dreaded disease. What I’m doing is actively mastering what’s making me feel anxious and worried, and in that way I’m attempting to feel I have some control over what’s happening.”

Sure, Dr. Eger went through standard self-delusions. ”There was a kind of twilight zone when you’re not healthy, but not in pain and not feeling major symptoms: ‘I avoided the bullet. Maybe it’ll just stay mild and progress very, very slowly and I’ll be one of the lucky people.’ ”

But the disease’s ”creeping into all corners of my life” set him straight. He could tell on the faces of his children — Jonathan, a doctoral student in psychology, and Molly, a college freshman — that they noticed the deterioration.

”For a while, they didn’t like to see that I was having difficulty walking and having tremors,” Dr. Eger said. ”They wanted me to be well.”

His patients asked about the trembling. Although psychologists often avoid revealing anything personal, turning a question on the patient, this was a subject he could not avoid.

There are discouraging moments. ”It’s easy to imagine the worst,” he said. ”When you see people who aren’t able to function well at all, you feel not only compassion, but you ask yourself: ‘Is that my future?’ ”

But like Mr. Fox, who titled his memoir ”Lucky Man,” Dr. Eger has come to the conclusion, perhaps Pollyannaish but effective, that Parkinson’s opened up new worlds. It has given him a chance to absorb the worst, and, he said, not ”allow myself to be a victim of my illness.” It has taught him that even though there is a fighter inside him who raised all that money, it is all right sometimes to be less self-sufficient, to appreciate a friend’s help for something as small as buttoning a shirt cuff.

Nun Credits Pope John Paul With Healing Her Parkinson’s Disease

ROME (AP) It’s one of the Roman Catholic Church’s closely guarded secrets: the identity of the French nun whose testimony of an inexplicable cure from Parkinson’s disease is likely to be accepted as the miracle the Vatican needs to beatify Pope John Paul the Second.

The nun is expected to be in Rome for ceremonies Monday marking the second anniversary of the pontiff’s death and the closure of a church investigation into his life — a probe that was ordered after chants of “Sainthood Now!” erupted during John Paul’s 2005 funeral.

It’s not clear whether the nun will come forward publicly next week, or leave the faithful with only an anonymous written description of her cure from a disease John Paul lived with for years.

The Vatican requires that a miracle attributed to his intercession be confirmed before he can be beatified, the last formal step before possible sainthood.

Sixty Plus: Parkinson’s journey is personal

The story of each person’s journey with Parkinson’s disease is as unique as the individual. An estimated 1 million Americans have the disease — more than 1,500 in Vermont alone.Most people associate Parkinson’s with Michael J. Fox. The actor’s tremors and difficulty speaking have put a public face on a disease that is rarely discussed.What causes Parkinson’s is unknown, and though medical advances have helped treat the symptoms, there is no cure for this chronic and progressive disease.

“There is a natural progression, but everyone is different. How it advances or how long it takes is individually different,” says Mike O’Connor, president of the American Parkinson Disease Association Vermont Chapter. O’Connor has Parkinson’s.

Parkinson’s disease is a progressive degenerative neurological disorder of the brain caused by the death of cells that produce dopamine, a chemical that transmits brain signals involved in motor skills.

Most Parkinson’s patients are over age 60. Many people with the disease have it for years before diagnosis. Symptoms range from tremors, rigidity, Bradykinesia (slow movement) and impaired balance. Many others experience depression, sleep abnormalities, difficulty swallowing, and sometimes dementia or mood changes.

For Vivian Branschofsky of Granville, she first noticed she couldn’t wave her hand and her foot dragged. After her diagnosis, it took a while to get over the shock, but as she says eventually “you realize you are going to be living with this disease and not dying of it.”

For O’Connor, his business used to take him around the world. Now he stays close to home in Williston because the traveling is tiring. He also never knows when he will have a good day or a bad one. His handwriting can be illegible sometimes, he says.

For people living with Parkinson’s, there is always that fine line of balancing the symptoms of the disease with the side effects of the medication. Without the medication, the symptoms make living almost impossible and the pain can be unbearable. However, with the medications, serious complications can occur.

Cassie Blanchard of Williamstown discovered a slight adjustment in meds can have a profound impact. One day as she was getting in a bath, she froze.

“I always hold onto the pole when I get in the tub, and I went down and I couldn’t get back up, and I thought oh my god I can’t get myself back up. I was pulling my head back up and yelling for my husband who had to pull me out of the tub,” she says.

Blanchard is a busy mother of three, with early onset Parkinson’s. She has to balance the symptoms of the disease with challenges of being a mom. Her youngest daughter has “cried before, saying it is not fair that she only knows her as Parkinson Mommy.”

People living with Parkinson’s might begin to retreat. “One of the problems with Parkinson’s is you tend to disappear,” Branschofsky says. “You don’t go out and do as many things anymore because it is too hard. … You may feel embarrassed, for example, if you have difficulty feeding yourself.”

For Susan Werntgen of Moretown, her world changed when her husband, Ralph, was diagnosed. “Parkinson’s has taken over our life,” she says. Her husband cannot drive and is homebound.

“Life really narrows,” Werntgen says. “My children have seen their dad deteriorate, a huge loss. You lose your partner.”

Support groups help those living with Parkinson’s and caring for those with the disease. For caregivers “there is a lot of isolation,” Werntgen says. Meeting with other caregivers helps you know “you are not the only person going through these challenges.”

Gov. Jim Douglas will proclaim Saturday as Parkinson’s Awareness Day at the Cortina Inn in Killington. O’Connor, Blanchard, Branschofsky and Werntgen will attend to meet with people living with Parkinson’s and support caregivers.

Sarah Lemnah writes on senior issues for the Champlain Valley Agency on Aging, a private, nonprofit United Way organization. For more information on services for seniors call the Senior HelpLine at (800) 642-5119.

 

 

Parkinson’s Disease Does Not Have to Come Between You and Your Loved One

Parkinson’s Disease Does Not Have to Come Between You and Your Loved One 

If you are a caregiver you probably have a close relationship with the person you are caring for. Whether it’s your spouse, your mother or father, friend or other relative, it’s very important for you both to realize that the problems you are facing are not from the person, but the disease.

Parkinson’s is a disease that could come between the two of you, and you have to be careful not to let it. You have to find things that you can still do together or find new things that you both can enjoy.

Whether it’s watching TV or whatever, you have to find ways of doing things together that are fun and not a struggle for the person with PD and that don’t require patience on the part of the caregiver.

“It can be very easy to lose the relationship you have with one another and just become the caregiver and care receiver. You lose the sense of being a man and a woman, of being husband and wife, of lovers, of companions and friends”, Dave says.

“You need to make a very concerted effort to do the types of things to maintain that sense of relationship above and beyond being a caregiver and care receiver”.

Ali’s legacy ranks with the greatest

Ali’s legacy ranks with the greatest 
By all accounts, Muhammad Ali turned 65 in peace and quiet Wednesday. There was a time when those words peace, quiet and Ali would not have been mentioned in the same paragraph, but “The Greatest” is fighting a fight he never asked for against Parkinson’s disease.
Source: www.chicagotribune.com   

Do statin users risk Parkinson’s  
Scientists plan a large study to explore whether cholesterol-lowering drugs are linked to Parkinson’s disease.
Source: news.bbc.co.uk

Statins feared to cause Parkinson’s 
Scientists are examining whether there is a link between cholesterol-containing statins and Parkinson’s disease. Researchers at the University of North Carolina, who had undertaken research on a limited group, have found a link between low-density lipoprotein (LDL) cholesterol levels and Parkinson’s and they now want to probe deeper whether the cholesterol-lowering statins are responsible for …
Source: www.earthtimes.org
parkinson disease dissertation

|